A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO)

Clinical trial NCT00486018 · COMPLETED

Trial details

NCT number: NCT00486018
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Macular Edema Retinal Vein Occlusion

Start date: 2007-07-01
Primary completion: 2009-05-01
Enrollment: 397

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.